BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

North America

FDA Approves Subcutaneous Leqembi Iqlik, Ushering in a New Era of Alzheimer’s Treatment

U.S. Food and Drug Administration (FDA) announced its approval of a subcutaneous formulation of Leqembi (lecanemab), branded as Leqembi Iql...

September 01, 2025 | News

China’s D3 Bio Secures FDA Breakthrough and Orphan Drug Designations for KRAS G12C Inhibitor D3S-001

Breakthrough Therapy Designation was granted for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cel...

August 29, 2025 | News

Hope Biosciences Receives First RMAT Designation For Stem Cell Therapy In Multiple Sclerosis

Leading U.S. stem cell banking and cellular therapeutic manufacturer Hope Biosciences announces the U.S. Food and Drug Administration (FDA) has g...

August 28, 2025 | News

Pfizer And BioNTech Receive FDA Approval For LP.8.1-Adapted COVID-19 Vaccine For 2025-2026 Season

The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strain...

August 28, 2025 | News

Northwest Biotherapeutics To Acquire Advent BioServices, Bringing Manufacturing Operations In-House

Northwest Biotherapeutics, Inc. , a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that it ha...

August 28, 2025 | News

iNtRON Bio Files Patents for Groundbreaking IMPA™ Gene-Editing Technology Targeting Pasteurella Bacteriophages

Development of gene-editing technology for Pasteurella bacteriophages using the IMPA™ platform Establishment of an advanced platform tec...

August 27, 2025 | News

AbbVie To Acquire Gilgamesh’s Lead Psychedelic Compound Bretisilocin For Up To $1.2 Billion

Gilgamesh's lead asset, bretisilocin (GM-2505), is a potential best-in-class psychedelic compound currently in Phase 2 development for the treatment of m...

August 26, 2025 | News

Esaote’s MyLab™ A50 and MyLab™ A70 Ultrasound Systems Achieve FDA Approval

Esaote – one of the world's leading medical imaging companies - is proud to announce that the MyLab™ A50 and MyLab™ A...

August 25, 2025 | News

Lighthouse Pharma Secures $49.2M NIH Grant to Launch Phase 2 Alzheimer’s Trial in the United States

Groundbreaking Clinical Trial to Enroll 300 Patients in Double-Blind, Placebo-Controlled Study of Lysine-Gingipain Inhibitor Lighthouse Pharmaceuticals, a...

August 25, 2025 | News

Piramal Pharma Solutions and NewAmsterdam Pharma Expand Global OSD Manufacturing with Facilities in USA and India

Piramal Pharma Solutions, a global leader in contract development and manufacturing (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), ...

August 25, 2025 | News

Thermo Fisher Expands U.S. Footprint with New $192.5M Manufacturing Center in North Carolina

Thermo Fisher Scientific Inc., the world leader in serving science, announced the grand opening of its innovative manufacturing center of excellence ...

August 22, 2025 | News

Andelyn Biosciences Partners with Amplo Biotechnology to Advance AAV Gene Therapies for NMJ Disorders

Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered wi...

August 22, 2025 | News

XtalPi and Dong-A ST Sign MOU to Accelerate AI-Driven Drug Discovery in Immunology and Inflammation

XtalPi announced on the 20th that it signed a Memorandum of Understanding (MOU) with Korea's leading pharmaceutical company Dong-A ST, to jointl...

August 21, 2025 | News

Ginkgo Bioworks Partners with Inductive Bio and Tangible Scientific to Deliver AI-Driven Lab-in-the-Loop Drug Discovery

Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced that its Datapoints offering ...

August 21, 2025 | News

Stay Connected